This trial is testing hydroxychloroquine, an FDA-approved medicine for the prevention and treatment of malaria. This is the first clinical trial to determine if hydroxychloroquine is effective in preventing COVID-19 in humans.
Other News
With students, many staff, faculty, and researchers already on campus, and others making plans to return this fall, I want to acknowledge…
A study conducted by the UMN College of Veterinary Medicine found that household cats were more susceptible than dogs to natural infection…
As the first trial of its kind, researchers will use common and widely available drugs to treat symptoms of COVID-19. This story was…